Scotch Plains, NJ, United States of America

Emma R Parmee

USPTO Granted Patents = 43 


 

Average Co-Inventor Count = 4.7

ph-index = 12

Forward Citations = 431(Granted Patents)


Location History:

  • Hoboken, NJ (US) (1995 - 1998)
  • Highland Park, NJ (US) (2000)
  • Scotch Plains, NJ (US) (2000 - 2014)
  • Doylestown, PA (US) (2013 - 2017)

Company Filing History:


Years Active: 1995-2017

Loading Chart...
Loading Chart...
Loading Chart...
43 patents (USPTO):

Title: Unveiling the Ingenious Inventor Emma R Parmee

Introduction

Emma R Parmee, a brilliant inventor hailing from Scotch Plains, NJ, has left an indelible mark in the field of pharmaceutical innovations. With an impressive portfolio of 43 patents, Parmee's groundbreaking work has significantly contributed to advancements in treating type 2 diabetes and related conditions.

Latest Patents

Parmee's recent patents showcase her commitment to developing cutting-edge solutions for medical challenges. One of her latest inventions includes Glucagon receptor antagonist compounds, known for their long duration of action and efficacy in managing type 2 diabetes. Additionally, her research on 2-pyridinecarboxamide derivatives has paved the way for novel treatments targeting glucokinase activation in diabetes patients.

Career Highlights

Having worked at renowned companies like Merck Sharp & Dohme Corporation and Merck & Company, Inc., Parmee has demonstrated her expertise in translating scientific discoveries into tangible solutions. Her innovative approach and dedication to improving patient outcomes have earned her accolades within the pharmaceutical industry.

Collaborations

Parmee's collaborative efforts with accomplished professionals like Ann E Weber and Ronald M Kim have fostered a culture of innovation and excellence. By synergizing their expertise, they have been instrumental in bringing forth novel pharmaceutical compositions and treatment methods for complex medical conditions.

Conclusion

In conclusion, Emma R Parmee's trailblazing work in the field of pharmaceutical inventions continues to redefine the landscape of diabetes treatment. Her relentless pursuit of innovation, coupled with her exceptional collaborations, reaffirms her status as a visionary inventor committed to shaping a healthier future for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…